Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs)
摘要:
In this Letter, we report on diarylpyridinone, diarylpyridazinone and diarylphthalazinone analogs as potential inhibitors of HIV-1 nonnucleoside reverse transcriptase (NNRTIs). The most promising compounds in these series are three diarylpyridazinones 25a, 25I and 25n which demonstrated submicromolar activity against wild-type HIV-1 and moderate activity against the single mutant strain Ba-L V106A. (C) 2011 Elsevier Ltd. All rights reserved.
Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs)
摘要:
In this Letter, we report on diarylpyridinone, diarylpyridazinone and diarylphthalazinone analogs as potential inhibitors of HIV-1 nonnucleoside reverse transcriptase (NNRTIs). The most promising compounds in these series are three diarylpyridazinones 25a, 25I and 25n which demonstrated submicromolar activity against wild-type HIV-1 and moderate activity against the single mutant strain Ba-L V106A. (C) 2011 Elsevier Ltd. All rights reserved.
Substrate Activity Screening with Kinases: Discovery of Small-Molecule Substrate-Competitive c-Src Inhibitors
作者:Meghan E. Breen、Michael E. Steffey、Eric J. Lachacz、Frank E. Kwarcinski、Christel C. Fox、Matthew B. Soellner
DOI:10.1002/anie.201311096
日期:2014.7.1
Substrate‐competitive kinaseinhibitors represent a promising class of kinaseinhibitors, however, there is no methodology to selectively identify this type of inhibitor. Substrateactivityscreening was applied to tyrosine kinases. By using this methodology, the first small‐molecule substrates for any protein kinase were discovered, as well as the first substrate‐competitive inhibitors of c‐Src with
底物竞争性激酶抑制剂代表了一类很有前途的激酶抑制剂,但是,没有方法可以选择性地识别这种类型的抑制剂。底物活性筛选应用于酪氨酸激酶。通过使用这种方法,发现了任何蛋白激酶的第一个小分子底物,以及第一个在生化和细胞测定中均具有活性的 c-Src 底物竞争性抑制剂。先导抑制剂的表征表明底物竞争性激酶抑制剂具有独特的性质,包括与生化效力相匹配的细胞功效以及与 ATP 竞争性抑制剂的协同作用。